DOI QR코드

DOI QR Code

Effects of Chicken Treated with Hwangki-Beni Koji Sauces on Body Weight, Serum and Hepatic Lipid Profiles of Rats Fed High Fat and High Cholesterol Diets

황기홍국소스를 처리한 계육이 고지방 및 고콜레스테롤 식이 흰쥐의 체중과 혈청 및 간 조직의 지질 함량에 미치는 영향

  • Kim, Jae-Won (Department of Food Science and Technology, Catholic University of Daegu) ;
  • Kim, Soon-Dong (Department of Food Science and Technology, Catholic University of Daegu) ;
  • Youn, Kwang-Sup (Department of Food Science and Technology, Catholic University of Daegu)
  • 김재원 (대구가톨릭대학교 식품가공학) ;
  • 김순동 (대구가톨릭대학교 식품가공학) ;
  • 윤광섭 (대구가톨릭대학교 식품가공학)
  • Received : 2010.05.25
  • Accepted : 2010.07.01
  • Published : 2010.09.30

Abstract

Dietary effects of chicken treated with Hwangki-Beni Koji sauces (HBS) on serum and hepatic lipid profiles in rats fed high a fat and high cholesterol diet were investigated. Experimental plots (5 rats per each group) were divided into normal control diet group (NC), high fat and high cholesterol diet group (HFC), HFC plus 15% base sauce treated chicken supplemented diet group (HFC-BS), HFC plus 15% HBS-treated chicken supplemented diet group (HFC-HBS), and fed for 5 weeks. Feed intakes in HFC-HBS group were higher than those of HFC and HFC-BS groups, whereas body weight gain and feed efficiency ratio of the HFC-HBS group were lower than those of the HFC and HFC-BS groups. Serum alanine aminotransferase and aspartate aminotransferase activities of HFC-HBS group were significantly lower than those of HFC and HFC-BS groups. Level of serum triglyceride, total cholesterol and LDL-cholesterol in HFC-HBS group were 34.06%, 6.28% and 31.00% lower than those of HFC-BS group, respectively, whereas HDL-cholesterol level and atherogenic index in HFC-HBS group were 1.72-fold higher and 2.52-fold lower, respectively, than those of HFC-BS group. Level of hepatic total lipid, triglyceride and total cholesterol in HFC-HBS group were 9.53%, 5.25% and 22.20% lower than those of HFC-BS group, respectively. In the morphological results of liver, the hepatocytes of central vein lesion and intact hepatic cell plate are preserved well from steatosis in HFC-HBS group, whereas the hepatocytes in HFC and HFC-BS groups are distended by accumulation of multiple fat droplets, and sinusoids are occluded. In the above results, we expected that chicken treated with Hwangki-Beni Koji sauce may have functionalities of anti-obesity, anti-cholesterol and also, lowering anti-atherogenic index in high fat and high cholesterol diets.

황기열수추출물(WEH)과 홍국 70% 에탄올추출물(EEB) 및 Monascus pilosus 액침배양액(LBK)을 동결건조한 등량 혼합물을 일반 베이스소스에 0.225% 혼합한 황기홍국소스(HBS)에 침지한 계육의 식이가 고지방-고콜레스테롤 병행식이 흰쥐의 체중, 장기중량, 혈청지질 함량에 미치는 영향을 조사하였다. 실험군은 정상군(NC), 고지방-고콜레스테롤 대조군(HFC), 고지방-고콜레스테롤 식이에 베이스소스를 처리한 계육을 15% 첨가한 식이군(HFC-BS) 및 고지방-고콜레스테롤 식이에 황기홍국소스를 처리한 계육을 15% 첨가한 식이군(HFC-HBS)으로 구분하여(5 마리/군) 5주간 사육하였다. 식이섭취량은 HFC-HBS군이 HFC 및 HFCBS군에 비하여 높았으나 식이효율과 사육후의 체중은 낮아 체중감소효과가 확인되었다. ALT 및 AST의 활성도 정상군에는 미치지 못하나 HFC군 및 HFC-BS군에 비하여 현저한 감소를 보였다. HFC-HBS군은 HFC-BS군에 비하여 혈청 triglyceride 함량은 34.06%, total cholesterol 함량은 6.28% 및 LDL-cholesterol 함량은 31.00%가 감소하였으며 HDL-cholesterol 함량은 1.72배 증가되었고 동맥경화지수는 2.52배 감소하였다. 간 조직의 총 지질, 중성지질 및 총콜레스테롤 함량도 HFC-HBS군이 HFC-BS군에 비하여 각각 9.53%, 5.25% 및 22.20%가 감소되었다. NC군은 정상적인 간 조직구조를 나타낸 반면 HFC군은 거의 모든 간세포가 multiple micro vesicles 형태의 지방을 함유하는 것으로 나타났다. 또한 HFC-BS군에서는 HFC군과 비교해 볼 때 소적형 지방축적은 감소되었으나 염증세포와 쿠퍼세포가 활성화된 모습을 보인 반면 HFC-HBS군은 HFC-BS군과 비교해 볼 때 간 실질세포 내 지방들은 아주 작은 포말형으로 나타나며 정상적인 간 실질세포의 형태가 잘 나타나 고지방-고콜레스테롤 식이로 인한 간세포 손상을 크게 완화시킨 것으로 사료된다.

Keywords

References

  1. Carr MC. 2003. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88: 2404-2411. https://doi.org/10.1210/jc.2003-030242
  2. Chu MA, Choe BH. 2010. Obesity and metabolic syndrome among children and adolescents in Korea. J Korean Med Assoc 53: 142-152. https://doi.org/10.5124/jkma.2010.53.2.142
  3. Lee K, Lim HT, Park SM. 2010. Factors associated with use of breast cancer screening services by women aged greater than or equal to 40 years in Korea: The Third Korea National Health and Nutrition Examination Survey 2005 (KNHANES III). BMC Cancer 10: 144. https://doi.org/10.1186/1471-2407-10-144
  4. National Health Statistics National Health and Nutrition Examination Survey 2008.
  5. Korean National Statistical Office. 2007 National Health and Nutrition Survey.
  6. Nieves J. 2005. Osteoporosis: the role of micronutrients. Am J Clin Nutr 81: 1232-1239. https://doi.org/10.1093/ajcn/81.5.1232
  7. Paigen B. 1995. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am J Clin Nutr 62: 458-462. https://doi.org/10.1093/ajcn/62.2.458S
  8. National Rural Resources Development Institute, RDA. 2006. Seventh Revision Food Composition Table II. Hyoil Press, Seoul, Korea. p 316-328.
  9. Viveros A, Centeno C, Arija I, Brenes A. 2007. Cholesterollowering effects of dietary lupin (Lupinus albus var Multolupa) in chicken diets. Poul Sci 86: 2631-2638. https://doi.org/10.3382/ps.2007-00128
  10. Bang JK, Kim JK, Song J, Lee BK. 2002. Comparison of constituents from the roots of Astragalus membranceus. Treat Crop Res 37: 39-42.
  11. Lin LZ, He XG, Lindermajer M, Nolan G, Yang J, Cleary M, Qiu SX, Cordell GA. 2000. Liquid chromatography-electrospray ionization mass spectrometry study of the flavonoids of the roots of Astragalus mongholicus and A. membranaceus. J Chromatogr 876: 87-95. https://doi.org/10.1016/S0021-9673(00)00149-7
  12. Kitagawa I, Wang HK, Yoshikawa M. 1983. Saponin and sapogenol. XXXVI. Chemical constituents of astragali radix, the root of Astragalus membranaceus BUNGE. (3) Astragalosides III, V, and VI. Chem Pharm Bull 31: 709-715. https://doi.org/10.1248/cpb.31.709
  13. Baek NI, Kim YS, Kyung JS, Park KH. 1996. Isolation of anti-hepatotoxic from the root of Astragalus membranceus. Kor K Pharmacogn 27: 111-116.
  14. Jung HS, Lee EJ, Lee JH, Kim JS, Kang SS. 2008. Phytochemical studies on Astragalus root (3): triterpenoids and sterols. Kor J Pharmacogn 39: 186-193.
  15. Rios JL, Waterman PG. 1997. A review of the pharmacology and toxicology of Astragalus. Phytother Res 11: 411-418. https://doi.org/10.1002/(SICI)1099-1573(199709)11:6<411::AID-PTR132>3.0.CO;2-6
  16. Ryu MS, Kim EH, Chun MS, Kang SH, Shim BS, Yu YB, Jeong GJ, Lee JS. 2008. Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk. J Ethnopharmacol 115: 184-193. https://doi.org/10.1016/j.jep.2007.09.027
  17. Martinkova L, Juzlova P, Vesely D. 1995. Biological activity of polyketide pigments produced by the fungus Monascus. J Appl Bacteriol 79: 609-616. https://doi.org/10.1111/j.1365-2672.1995.tb00944.x
  18. Kim EY, Rhyu MR. 2008. Antimicrobial activities of Monascus koji extracts. Korean J Food Sci Technol 40:76-81.
  19. Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kimura M. 2003. Blood-pressure-lowering effect of a novel fermented milk containing $\gamma$-aminobutyric acid in mild hypertensives. Eur J Clin Nutr 57: 490-495. https://doi.org/10.1038/sj.ejcn.1601815
  20. Kang MR, Kim JY, Hyun YJ, Kim HJ, Yeo HY, Song YD, Lee JH. 2008. The effect of red-yeast-rice supplement on serum lipid profile and glucose control in subjects with impaired fasting glucose or impaired glucose tolerance. Korean J Nutr 41: 31-40.
  21. Yasukawa K, Takahashi M, Yamanouchi S, Takido M. 1996. Inhibitory effect of oral administration of Monascus pigment on tumor promotion in two-stage carcinogenesis in mouse skin. Oncol 53: 247-249. https://doi.org/10.1159/000227568
  22. Youn UK, Kim YH, Kim SD. 2003. Pigment and monacolin K content of beni-koji fermented with soybean curd residue. Korean J Food Preserv 10: 360-364.
  23. Kroeger M. 2006. How omics technologies can contribute to the ‘3R’ principles by introducing new strategies in animal testing. Trends Biotech 24: 343-346. https://doi.org/10.1016/j.tibtech.2006.06.003
  24. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
  25. Reitman S, Frankel S. 1957. A colorimetric method for the determination of serum glutamic oxaloacetic pyruvic transaminase. Am J Clin Pathol 28: 56-63. https://doi.org/10.1093/ajcp/28.1.56
  26. Folch J, Lees M, Sloane GH. 1957. A simple method for isolation and purification of total lipids from animal tissue. J Biol Chem 226: 497-509.
  27. Frings CS, Dunn RT. 1970. A colorimetric method for determination of total serum lipid based on the sulfo-phosphovanillin reaction. Am J Clin Path 53: 89-91. https://doi.org/10.1093/ajcp/53.1.89
  28. Lowry OH, Rosebrough NJ, Farr AL, Randall RL. 1951. Protein measurement by Folin phenol reagent. J Biol Chem 193: 265-275.
  29. Degertekin H, Aldamar K, Yates R, Chen I, Ertan A, Vaupel R. 1986. Light and electron microscopic studies of diet-induced hepatic changes in mice. Acta Anatomica 125: 174– 179. https://doi.org/10.1159/000146157
  30. Lee JM, Cho WK, Park HJ. 1998. Effect of chitosan treated with enzymatic methods on glucose and lipid metabolism in rats. Korean J Nutr 31: 312-318.
  31. Mo EK, Jegal SA, Im DK, Lee ML, Sung CK. 2006. Characteristics and preparation of Jeung-Pyun (Korean fermented rice cake) according to Monascus rubber DSJ-20 as leavening agent. Korean J Food Sci Technol 38: 88-92.
  32. Yu MH, Lee HH, Im HG, Hwang Bo MH, Kim JH, Lee IS. 2005. The effects of kimchi with Monascus purpureus on the body weight gain and lipid metabolism in rats fed high fat diet. J Life Sci 15: 536-541. https://doi.org/10.5352/JLS.2005.15.4.536
  33. Wu YG, Xia LL, Lin H, Zhou D, Qian H, Lin ST. 2007. Prevention of early liver injury by breviscapine in streptozotocin- induced diabetic rats. Planta Med 73: 433-438. https://doi.org/10.1055/s-2007-967182
  34. Tang W, Eisenbrand G. 1992. Chinese drugs of plant origin chemistry, pharmacology and use in traditional and modern medicine . Spinger, Berlin, Germany. p 191.
  35. Reitman S, Frankel S. 1957. A colorimetric method for the determination of serum glutamic oxaloacetic pyruvic transaminase. Am J Clin Pathol 28: 58-63.
  36. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL,Torbenson MS, Polotsky VY. 2007. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 293: 871–877. https://doi.org/10.1152/ajpgi.00145.2007
  37. Zhang ZL, Wen QZ, Liu CX. 1990. Hepatoprotective effects of Astraglus root. J Ethnopharmacol 30: 145-149. https://doi.org/10.1016/0378-8741(90)90003-C
  38. Oh JD, Yoon CG, Yu TS. 2004. Effect of dietary Monascus koji on the liver damage induced by bromobenzene in rats. J Korean Soc Food Sci Nutr 33: 965-972. https://doi.org/10.3746/jkfn.2004.33.6.965
  39. Wilson JN, Wilson SP, Eator RP. 1984. Dietary fiber and lipoprotein metabolism in the genetically obese Zucker rat. Arteriosclerosis 4: 147-153. https://doi.org/10.1161/01.ATV.4.2.147
  40. Lee IS, Lee SW, Lee IZ. 2003. Effects of tissue cultured ginseng on blood glucose and lipid in streptozotocin-induced diabetic rats. Korean J Food Sci Technol 35: 280-285.
  41. Gordon T, Kannel WB, Castelli WP, Thomase R, Dawber TR. 1981. Lipoproteins, cardiovascular disease, and death: the Framingham Study. Arch Intern Med 141: 1128-1131. https://doi.org/10.1001/archinte.141.9.1128
  42. Park BH, Beck KY, Lee SI, Kim SD. 2006. Effect of chitosan- ascorbate containing soyfiber beni-koji on body weight and lipid content of obesity rats aid induced from high fat diet. J East Asian Soc Dietary Life 16: 663-669.
  43. Ryu KS, Kang CW, Song GS, Paik SW. 1998. Effect of dietary supplemental Astragalus membranaceus on performance, blood components and meat quality of broiler chicks. K J Poult Sci 25: 185-193.
  44. Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL. 1999. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 69: 231-236. https://doi.org/10.1093/ajcn/69.2.231
  45. Li C, Zhu Y, Wang Y, Zhu JS, Chang J, Kritchevsky D.1998. Monascus purpureus-fermented rice (red yeast rice): A natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr Res 18: 71-81. https://doi.org/10.1016/S0271-5317(97)00201-7
  46. Wang J, Lu Z, Chi J, Wang W, Su M, Kou W, Yu P, Yu L, Chen L, Zhu JS, Chang J. 1997. Multicenter clinical trial of the serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Curr Therap Res 58: 964-978. https://doi.org/10.1016/S0011-393X(97)80063-X
  47. Arad Y, Ramakrishnan R, Ginsberg HN. 1990. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. J Lipid Res 31: 567-582.
  48. Purmova J, Opletal L. 1995. Phytotherapeutic aspects of diseases of the cardiovascular system. 5. Saponins and possibilities of their use in prevention and therapy. Ceska Slov Farm 44: 246-251.
  49. Bedir E, Pugh N, Calis I, Pasco DS, Khan IA. 2000. Immunostimulatory effects of cycloartane-type triterpene glycosides glycosides from astragalus species. Biol Pharm Bull 23: 834-837. https://doi.org/10.1248/bpb.23.834
  50. Cha JY, Park JC, Ahn HY, Eom KE, Park BK, Jun BS, Lee CH, Cho YS. 2009. Effect of Monascus purpureus fermented Korean red ginseng powder on the serum lipid levels and antioxidative activity in rats. J Korean Soc Food Sci Nutr 38: 1153-1160. https://doi.org/10.3746/jkfn.2009.38.9.1153
  51. Kang SM, Shin JY, Hwang SJ, Hong SG, Jang HE, Park MH. 2003. Effects of Saengshik supplementation on health improvement in diet-induced hypercholesterolemic rats. J Korean Soc Food Sci Nutr 32: 906-912. https://doi.org/10.3746/jkfn.2003.32.6.906
  52. Yao T, Sato M, Kobayashi Y, Wasa T. 1985. Amperometric assays of total and free cholesterol in serum by the combined use of immobilized cholesterol esterases and cholesterol oxidant reactors and peroxidase electrode in a flow injection system. Anal Biochem 149: 387-391. https://doi.org/10.1016/0003-2697(85)90587-1
  53. Hulcher H, Oleson WH. 1973. Simplified spectrophotometric assay for HMG-Co A reductase. J Lipid Res 14: 625-631.
  54. Endo A. 1979. Monacolin-K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiot (Tokyo) 32: 852-854. https://doi.org/10.7164/antibiotics.32.852
  55. Popper H, Schaffner F. 1986. Progress in liver disease:nonalcoholic fatty liver disease. Schaffner F, Thaler H, eds. Grune & Stratton, Orlando, USA. Vol 8, p 283-298.
  56. Grundmann E, Geller SA. 1992. Histopathology: Color atlas of organs and systems. Urban & Schwarzenberg, Baltimore, USA. p 105.
  57. Franke WW, Denk H, Schmid E, Osborn M, Weber K. 1979. Ultrastructural, biochemical and immunological characterization of Mallory bodies in livers of griseofulvin-treated mice: Fimbriated rods of filaments containing prekeratin- like polypeptides. Lab Invest 40: 207-220.

Cited by

  1. Anti-obesity Effect of Monascus pilosus Mycelial Extract in High Fat Diet-induced Obese Rats vol.54, pp.3, 2011, https://doi.org/10.3839/jabc.2011.033
  2. Antioxidant Activity of Hwangki and Beni-Koji Extracts and Mixture vol.40, pp.1, 2011, https://doi.org/10.3746/jkfn.2011.40.1.001
  3. Protective Effect of Monascus pilosus Mycelial Extract on Hepatic Damage in High-Fat Diet Induced-obese Rats vol.54, pp.3, 2011, https://doi.org/10.3839/jabc.2011.034